Maggie Jackson

Director, Trade & Channel Strategy at Teva Pharmaceuticals

Speaker

Maggie Jackson is a Director of Trade and Channel Strategy at Teva Pharmaceuticals, where she leads launch planning, portfolio management, DTP program development, contracting, and policy/market landscape changes in relation to Trade and Channel partners for Brand and Biosimilar products. With more than 15 years of experience within the pharma & biotech industry, Maggie specializes in navigating the intersection of pharmacy and distributor economics, payer dynamics, healthcare policy, and distribution strategy to improve patient access and commercial performance. Prior to Teva, Maggie led Trade Strategy and Operations efforts at Gilead Sciences focused on building out their specialty-focused portfolio, launch and sunset planning, re-evaluating legacy distribution strategies, and specialty pharmacy programs. Maggie holds a bachelor’s degree in Biomathematics and Philosophy as well as a Master’s in Biotechnology & Business.

Therapeutic background: Neurology, Psychiatry, Endocrinology, Retinopathy, Virology, Oncology (Biologics & CAR-T), Inflammation